Traws Pharma, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRAW and other ETFs, options, and stocks.About TRAW
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer.
CEOIain David Dukes
CEOIain David Dukes
Employees7
Employees7
HeadquartersNewtown, Pennsylvania
HeadquartersNewtown, Pennsylvania
Founded1998
Founded1998
Employees7
Employees7
TRAW Key Statistics
Market cap18.92M
Market cap18.92M
Price-Earnings ratio0.09
Price-Earnings ratio0.09
Dividend yield—
Dividend yield—
Average volume232.37K
Average volume232.37K
High today$2.40
High today$2.40
Low today$2.05
Low today$2.05
Open price$2.14
Open price$2.14
Volume438.12K
Volume438.12K
52 Week high$19.44
52 Week high$19.44
52 Week low$0.97
52 Week low$0.97
Stock Snapshot
The current Traws Pharma, Inc.(TRAW) stock price is $2.36, with a market capitalization of 18.92M. The stock trades at a price-to-earnings (P/E) ratio of 0.09.
During the trading session on 2025-12-04, Traws Pharma, Inc.(TRAW) shares reached a daily high of $2.40 and a low of $2.05. At a current price of $2.36, the stock is +15.2% higher than the low and still -1.7% under the high.
Trading volume for Traws Pharma, Inc.(TRAW) stock has reached 438.12K, versus its average volume of 232.37K.
The stock's 52-week range extends from a low of $0.97 to a high of $19.44.
The stock's 52-week range extends from a low of $0.97 to a high of $19.44.
People also own
Based on the portfolios of people who own TRAW. This list is generated using Robinhood data, and it’s not a recommendation.